Rhinitis, Allergic, Seasonal
Conditions
Keywords
pollinosis, quality of life, specific immunotherapy
Brief summary
Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro
Detailed description
Questionnaire including 19 questions concerning the Quality of life of patients with hayfeyer under or after therapy with a specific immuntherapy with Pollinex quattro
Interventions
OTHERQuality of life under or after therapy with Pollinex quattro
To measure Quality of life using the DLQI-index in year one, year two, year three or six month after therapy with Pollinex quattro plus.
Sponsors
Universität des Saarlandes
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pollinosis/seasonal Rhinitis based on an allergy against birch/alder/Hazel pollen OR grass/rye pollen OR mugwort * Therapy with Polinex quattro
Exclusion criteria
* Age \<18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life questionnaire (DLQI) | during year one, year two, year three of therapy or within 6 months after completion of therapy |
Countries
Germany
Outcome results
None listed